MedPath

PLERIXAFOR INJECTION

PLERIXAFOR INJECTION

Approved
DIN Number

02539454

Drug Class

Human

Market Date

Jan 5, 2024

Company
HC

eugia pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02539454
AIG Number0153050001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L03AX16 PLERIXAFOR
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PLERIXAFORActive
Strength: 20 MG / ML
Monograph: PLERIXAFOR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.